WordNet
- a substance that exerts some force or effect
- a businessman who buys or sells for another in exchange for a commission (同)factor, broker
- any agent or representative of a federal agency or bureau (同)federal agent
- a representative who acts on behalf of other persons or organizations
- an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
- how long something has existed; "it was replaced because of its age"
- a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
- begin to seem older; get older; "The death of his wife caused him to age fast"
- make older; "The death of his child aged him tremendously"
- a kind of pharmaceutical that can break up clots blocking the flow of blood to the heart muscle (同)thrombolytic_agent, clot buster
PrepTutorEJDIC
- 『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
- 〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 急性肺塞栓症および下肢深部静脈血栓症における線溶（血栓溶解）療法 fibrinolytic thrombolytic therapy in acute pulmonary embolism and lower extremity deep vein thrombosis
- 2. 急性虚血性脳卒中における経静脈的線維素溶解（血栓溶解）治療：治療的使用 intravenous fibrinolytic thrombolytic therapy in acute ischemic stroke therapeutic use
- 3. Fibrinolysis for acute ST elevation myocardial infarction: Initiation of therapy
- 4. ST上昇型心筋梗塞における血栓溶解療法の特性および臨床試験 characteristics of fibrinolytic thrombolytic agents and clinical trials in acute st elevation myocardial infarction
- 5. 下肢の急性動脈閉塞（急性下肢虚血）の概要 overview of acute arterial occlusion of the extremities acute limb ischemia
English Journal
- Non-activated protein C rescue treatment in Wilms tumour associated hepatic sinusoidal obstructive syndrome.
- De Leonardis F1, Koronica R, Bruno SD, Santoro N.Author information 1Division of Paediatric Haematology-Oncology, Department of Pediatrics, Bari, Italy.AbstractHepatic sinusoidal obstructive syndrome (HSOS) is a frequent complication in patients undergoing haematopoietic stem cell transplant (HSCT), and more rarely, in paediatric patients receiving conventional chemotherapy for solid tumours. Its diagnosis relies on a combination of clinical signs and symptoms such as hepatomegaly, jaundice, weight gain and fluid retention. HSOS treatment is primarily based on supportive care and anti-fibrinolytic agents. Here we report two patients affected by Wilms tumour who developed life-threatening HSOS that failed to respond to conventional treatment. Both patients recovered after receiving aggressive supportive treatment that included administration of non-activated protein C (Ceprotin®-Baxter). Pediatr Blood Cancer 2014;61:940-941. © 2013 Wiley Periodicals, Inc.
- Pediatric blood & cancer.Pediatr Blood Cancer.2014 May;61(5):940-1. doi: 10.1002/pbc.24859. Epub 2013 Nov 26.
- Hepatic sinusoidal obstructive syndrome (HSOS) is a frequent complication in patients undergoing haematopoietic stem cell transplant (HSCT), and more rarely, in paediatric patients receiving conventional chemotherapy for solid tumours. Its diagnosis relies on a combination of clinical signs and symp
- PMID 24281860
- Catheter-directed thrombolysis-assisted angioplasty for chronic lower limb ischemia.
- Zhang F1, Zhang H2, Luo X2, Liang G2, Feng Y2, Zhang WW3.Author information 1Beijing Shijitan Hospital, Beijing, China. Electronic address: fuxianvascular@yahoo.cn.2Beijing Shijitan Hospital, Beijing, China.3Department of Surgery, Louisiana State University Health Sciences Center, Shreveport, LA.AbstractBACKGROUND: Thrombolysis is an appropriate treatment for acute arterial occlusion. There remains controversy as to whether thrombolysis before angioplasty helps to identify the underlying lesion and improve results for chronic ischemia of the lower extremity. We sought to investigate the feasibility of catheter-directed thrombolysis-assisted angioplasty for chronic lower limb ischemia.
- Annals of vascular surgery.Ann Vasc Surg.2014 Apr;28(3):590-5. doi: 10.1016/j.avsg.2013.05.015. Epub 2013 Oct 25.
- BACKGROUND: Thrombolysis is an appropriate treatment for acute arterial occlusion. There remains controversy as to whether thrombolysis before angioplasty helps to identify the underlying lesion and improve results for chronic ischemia of the lower extremity. We sought to investigate the feasibility
- PMID 24667039
- Catheter Directed Thrombolysis for severe pulmonary embolism in pediatric patients.
- Bavare AC1, Naik SX2, Lin PH3, Poi MJ4, Yee DL5, Bronicki RA6, Philip JX7, Desai MS6.Author information 1Section of Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, 6621 Fannin Street, WT6-006, Houston, Texas. 77030. Electronic address: acbavare@texaschildrens.org.2Clinical Postdoctoral Fellow, Section of Hematology and Oncology, Department of Pediatrics, Baylor College of Medicine.3Professor of Surgery, Chief, Division of Vascular Surgery and, Endovascular Therapy, Texas Children's Hospital and Baylor College of Medicine.4Assistant Professor, Division of Vascular Surgery and, Endovascular Therapy, Texas Children's Hospital and Baylor College of Medicine.5Section of Hematology and Oncology, Department of Pediatrics, Baylor College of Medicine.6Section of Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine.7Assistant Professor, Congenital heart Center, Shands Hospital, University of Florida.AbstractOBJECTIVE: Catheter directed thrombolytic therapies (CDT) for severe pulmonary embolism (PE) have been shown to be effective and safe when compared to systemic thrombolysis in adults. Pediatric studies assessing efficacy and safety of CDT for PE are lacking. Hence our aim was to review CDT as a therapy for pediatric PE.
- Annals of vascular surgery.Ann Vasc Surg.2014 Mar 31. pii: S0890-5096(14)00183-6. doi: 10.1016/j.avsg.2014.03.016. [Epub ahead of print]
- OBJECTIVE: Catheter directed thrombolytic therapies (CDT) for severe pulmonary embolism (PE) have been shown to be effective and safe when compared to systemic thrombolysis in adults. Pediatric studies assessing efficacy and safety of CDT for PE are lacking. Hence our aim was to review CDT as a ther
- PMID 24698774
Japanese Journal
- Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- andtissue plasminogen activator-related brain damages in mice
- Takamiya M.,Miyamoto Y.,Yamashita T.,Deguchi K.,Ohta Y.,Abe K.
- Neuroscience 221, 47-55, 2012-09-27
- … Reactive oxygen species (ROS) are major exacerbation factor in acute ischemic stroke, and thrombolytic agent tissue plasminogen activator (tPA) may worsen motor function and cerebral infarcts. …
- NAID 120005300242
- Fibrinolytic enzyme from newly isolated marine bacterium Bacillus subtilis ICTF-1 : Media optimization, purification and characterization(ENZYMOLOGY, PROTEIN ENGINEERING, AND ENZYME TECHNOLOGY)
- Mahajan Prafulla M.,Nayak Shubhada,Lele Smita S.
- Journal of bioscience and bioengineering 113(3), 307-314, 2012-03-00
- … In vitro assays revealed that the enzyme could catalyze blood clot lysis effectively, indicating that this enzyme could be a useful thrombolytic agent. … The purified fibrinolytic enzyme showed high stability towards various surfactants and was relatively stable towards oxidizing agent. … Considering these properties purified fibrinolytic enzyme also finds potential application in laundry detergents in addition to thrombolytic agent. …
- NAID 110009425320
- 腸骨・大腿静脈の血管内治療が有効であった静脈血栓後症候群の2症例
- 斧田 尚樹
- 脈管学 52(June), 271-276, 2012
- 静脈血栓後症候群の治療は，日常生活指導や弾性ストッキングの着用といった保存的治療が主体であるが，難渋することも多い。圧迫療法が施行できない静脈血栓後症候群(CEAP C3)の2症例に血管内治療を施行した。閉塞部は器質化血栓と考えられたため血栓溶解剤は投与せず，バルーン形成術，ステント留置のみで再開通を行った。術後，3日以内に下肢腫脹は消失した。圧迫療法が施行できない自覚症状，徴候のある症例に対して …
- NAID 130001922087
Related Links
- thrombolytic agent Clot-dissolving drug, thrombolytic An agent–eg, tPA, streptokinase, that effects thrombolysis and restores vascular patency–eg, in ... This edition has been updated and rewritten to reflect current science and ...
- Definition of thrombolytic agent in the AudioEnglish.org Dictionary. Meaning of thrombolytic agent. What does thrombolytic agent mean? Proper usage and pronunciation (in phonetic transcription) of the word thrombolytic agent.
Related Pictures
★リンクテーブル★
| リンク元 | 「fibrinolytic agent」「thrombolytic drug」「antithrombotic agent」「血栓溶解剤」「血小板溶解薬」 |
| 関連記事 | 「agent」「thrombolytic」「age」「thrombolytics」 |
「fibrinolytic agent」
- 関
- antithrombotic agent、fibrinolytic drug、thrombolytic、thrombolytic agent、thrombolytic drug、thrombolytics
「thrombolytic drug」
- 関
- antithrombotic agent、fibrinolytic agent、fibrinolytic drug、thrombolytic、thrombolytic agent、thrombolytics
「antithrombotic agent」
「血栓溶解剤」
「血小板溶解薬」
「agent」
- n.
- 代行者、代理人。代理業者
- 政府職員、官吏
- ある後位をする人、ある作用をするもの。動員、動力因、作用因。(文法)動作主。科学的変化を起こさせるもの、薬品、～剤。病原体
- 関
- agonist、agonistic、attorney、delegate、drug、etiologic agent、fomes、fomites、mediator、pathogen、pathogenic、pharmaceutical preparation、vector、vehicle
「thrombolytic」
- adj.
- 血栓溶解の
- n.
「age」
- n.
- 年齢、歳
- v.
- 加齢する、熟成する